" class="no-js "lang="en-US"> Peng Yue - Medtech Alert
Saturday, July 26, 2025
Peng Yue

Peng Yue

About Peng Yue

Related Story

ReviR Therapeutics Appoints Paul August, Ph.D., as Chief Scientific Officer

July 4 2022

ReviR Therapeutics, a biotechnology company focused on developing RNA-targeting small molecule drugs, announced the appointment […]

ReviR Therapeutics Raises ~$20M in Pre-A Financing

January 18 2022

ReviR Therapeutics, a South San Francisco based biopharmaceutical company, completed a Pre-A financing round with ~$20M. The funds […]